ParkinsonCanadaV1, Main, Exploration, bibRecord, 002968

Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.

Identifieur interne : 002968 ( Main/Exploration ); précédent : 002967; suivant : 002969

Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.

Auteurs : Wing Lok Au [Canada] ; John R. Adams ; André R. Troiano ; A Jon Stoessl

Source :

Brain research. Molecular brain research [ 0169-328X ] ; 2005.

RBID : pubmed:15790527

English descriptors

KwdEn :
- Animals, Brain (diagnostic imaging), Disease Progression, Dopamine, Dopamine Plasma Membrane Transport Proteins, Humans, Membrane Glycoproteins, Membrane Transport Proteins, Models, Neurological, Nerve Tissue Proteins, Parkinson Disease (diagnostic imaging), Positron-Emission Tomography, Vesicular Biogenic Amine Transport Proteins.
MESH :
- chemical : Dopamine, Dopamine Plasma Membrane Transport Proteins, Membrane Glycoproteins, Membrane Transport Proteins, Nerve Tissue Proteins, Vesicular Biogenic Amine Transport Proteins.
- diagnostic imaging : Brain, Parkinson Disease.
- Animals, Disease Progression, Humans, Models, Neurological, Positron-Emission Tomography.

Abstract

Over the past two decades, positron emission tomography (PET) has provided valuable insights into the mechanisms of nigrostriatal degeneration in Parkinson's disease (PD). Furthermore, it allows the in vivo assessment of disease progression and the evaluation of treatment interventions. In this review, we shall discuss some of the issues and concerns that arise with the use of PET as a surrogate marker of disease progression in Parkinson's disease.

DOI: 10.1016/j.molbrainres.2004.09.028
PubMed: 15790527

Affiliations:

Canada

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.</title>
<author><name sortKey="Au, Wing Lok" sort="Au, Wing Lok" uniqKey="Au W" first="Wing Lok" last="Au">Wing Lok Au</name>
<affiliation wicri:level="1"><nlm:affiliation>Pacific Parkinson's Research Centre, University of British Columbia, Vancouver Hospital and Health Sciences Centre, Purdy Pavilion, 2221 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Pacific Parkinson's Research Centre, University of British Columbia, Vancouver Hospital and Health Sciences Centre, Purdy Pavilion, 2221 Wesbrook Mall, Vancouver, BC</wicri:regionArea>
<wicri:noRegion>BC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Adams, John R" sort="Adams, John R" uniqKey="Adams J" first="John R" last="Adams">John R. Adams</name>
</author>
<author><name sortKey="Troiano, Andre R" sort="Troiano, Andre R" uniqKey="Troiano A" first="André R" last="Troiano">André R. Troiano</name>
</author>
<author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15790527</idno>
<idno type="pmid">15790527</idno>
<idno type="doi">10.1016/j.molbrainres.2004.09.028</idno>
<idno type="wicri:Area/PubMed/Corpus">001279</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001279</idno>
<idno type="wicri:Area/PubMed/Curation">001279</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001279</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001279</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001279</idno>
<idno type="wicri:Area/Ncbi/Merge">000520</idno>
<idno type="wicri:Area/Ncbi/Curation">000520</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000520</idno>
<idno type="wicri:doubleKey">0169-328X:2005:Au W:parkinson:s:disease</idno>
<idno type="wicri:Area/Main/Merge">002C81</idno>
<idno type="wicri:Area/Main/Curation">002968</idno>
<idno type="wicri:Area/Main/Exploration">002968</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.</title>
<author><name sortKey="Au, Wing Lok" sort="Au, Wing Lok" uniqKey="Au W" first="Wing Lok" last="Au">Wing Lok Au</name>
<affiliation wicri:level="1"><nlm:affiliation>Pacific Parkinson's Research Centre, University of British Columbia, Vancouver Hospital and Health Sciences Centre, Purdy Pavilion, 2221 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Pacific Parkinson's Research Centre, University of British Columbia, Vancouver Hospital and Health Sciences Centre, Purdy Pavilion, 2221 Wesbrook Mall, Vancouver, BC</wicri:regionArea>
<wicri:noRegion>BC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Adams, John R" sort="Adams, John R" uniqKey="Adams J" first="John R" last="Adams">John R. Adams</name>
</author>
<author><name sortKey="Troiano, Andre R" sort="Troiano, Andre R" uniqKey="Troiano A" first="André R" last="Troiano">André R. Troiano</name>
</author>
<author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name>
</author>
</analytic>
<series><title level="j">Brain research. Molecular brain research</title>
<idno type="ISSN">0169-328X</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Brain (diagnostic imaging)</term>
<term>Disease Progression</term>
<term>Dopamine</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Humans</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Models, Neurological</term>
<term>Nerve Tissue Proteins</term>
<term>Parkinson Disease (diagnostic imaging)</term>
<term>Positron-Emission Tomography</term>
<term>Vesicular Biogenic Amine Transport Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Dopamine</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Vesicular Biogenic Amine Transport Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Brain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Models, Neurological</term>
<term>Positron-Emission Tomography</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Over the past two decades, positron emission tomography (PET) has provided valuable insights into the mechanisms of nigrostriatal degeneration in Parkinson's disease (PD). Furthermore, it allows the in vivo assessment of disease progression and the evaluation of treatment interventions. In this review, we shall discuss some of the issues and concerns that arise with the use of PET as a surrogate marker of disease progression in Parkinson's disease.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><noCountry><name sortKey="Adams, John R" sort="Adams, John R" uniqKey="Adams J" first="John R" last="Adams">John R. Adams</name>
<name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name>
<name sortKey="Troiano, Andre R" sort="Troiano, Andre R" uniqKey="Troiano A" first="André R" last="Troiano">André R. Troiano</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Au, Wing Lok" sort="Au, Wing Lok" uniqKey="Au W" first="Wing Lok" last="Au">Wing Lok Au</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002968 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002968 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:15790527
   |texte=   Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:15790527" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.

Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.